[STUDY OF ADRENAL CORTEX FUNCTION AFTER ADMINISTRATION OF HYDROCHLOROTHIAZIDE IN NORMAL SUBJECTS AND PATIENTS WITH ADRENAL GLAND DISEASES].
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D000224:Addison Disease; D000302:Adrenal Cortex; D000307:Adrenal Gland Diseases; D000309:Adrenal Insufficiency; D000308:Adrenocortical Hyperfunction; D000738:Androsterone; D003480:Cushing Syndrome; D003687:Dehydroepiandrosterone; D006801:Humans; D006852:Hydrochlorothiazide; D000075262:Hypoadrenocorticism, Familial; D007018:Hypopituitarism; D010600:Pharmacology; D010912:Pituitary-Adrenal Function Tests
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D006852:Hydrochlorothiazide; D003687:Dehydroepiandrosterone; D000738:Androsterone
17-HYDROXYCORTICOSTEROIDS; 17-KETOSTEROIDS; ADDISON'S DISEASE; ADRENAL GLAND DISEASES; ADRENAL GLAND HYPERFUNCTION; ANDROSTERONE; CUSHING'S SYNDROME; DEHYDROEPIANDROSTERONE; HYDROCHLOROTHIAZIDE; HYPOPITUITARISM; PHARMACOLOGY; PITUITARY-ADRENAL FUNCTION TESTS; SHEEHAN'S SYNDROME
STUDIO DELLA FUNZIONE CORTICOSURRENALICA DOPO CARCICO DI IDROCLOROTIAZIDE DOPO IN SOGGETTI NORMALI E SURRENOPATICI.